Article | Open | Published:

CO2 fixation by anaerobic non-photosynthetic mixotrophy for improved carbon conversion

Nature Communications volume 7, Article number: 12800 (2016) | Download Citation

Abstract

Maximizing the conversion of biogenic carbon feedstocks into chemicals and fuels is essential for fermentation processes as feedstock costs and processing is commonly the greatest operating expense. Unfortunately, for most fermentations, over one-third of sugar carbon is lost to CO2 due to the decarboxylation of pyruvate to acetyl-CoA and limitations in the reducing power of the bio-feedstock. Here we show that anaerobic, non-photosynthetic mixotrophy, defined as the concurrent utilization of organic (for example, sugars) and inorganic (for example, CO2) substrates in a single organism, can overcome these constraints to increase product yields and reduce overall CO2 emissions. As a proof-of-concept, Clostridium ljungdahlii was engineered to produce acetone and achieved a mass yield 138% of the previous theoretical maximum using a high cell density continuous fermentation process. In addition, when enough reductant (that is, H2) is provided, the fermentation emits no CO2. Finally, we show that mixotrophy is a general trait among acetogens.

Introduction

The production costs for most chemicals via microbial fermentation are currently high compared to oil-derived products primarily because of operating costs associated with feedstock and feedstock processing. Consequently, first and second generation bioproduct manufacturing processes are economically challenged, particularly in light of recent low oil prices. One way to mitigate high feedstock cost is to maximize conversion into the bioproduct of interest. This maximization, though, is limited because of the production of CO2 during the conversion of sugar into acetyl-CoA in traditional fermentation processes. Acetyl-CoA is a central building block and a link between glycolysis and almost all downstream metabolic pathways and serves as a focal point for the production of biofuels and industrial chemicals by microbial fermentations. However, the ability to achieve metabolically efficient production of acetyl-CoA is hindered by energetic requirements and biochemical pathway constraints, requiring the production of CO2 for every acetyl-CoA produced from glycolysis. Thus, one-third of all carbon in the feedstock is lost to CO2, resulting in maximum carbon conversion of 67% at best, and lower in actuality due to cell mass creation, cell maintenance needs and other constraints1.

It was previously demonstrated that a synthetic, non-oxidative glycolysis (NOG) pathway2,3 enables the stoichiometric conversion of certain sugars to acetyl-CoA; however, NOG does not generate adenosine triphosphate (ATP) without converting acetyl-CoA into acetate, and consumes all reducing equivalents (that is, NAD(P)H) produced from sugar. Consequently, NOG-based product yields are limited by both ATP and NAD(P)H when producing metabolites that are more reduced, on a carbon basis (that is, carbon degree of reduction), than the feedstock consumed.

A second, alternative approach that stoichiometrically converts sugar to acetyl-CoA is anaerobic, non-photosynthetic mixotrophic fermentation4 (here referred to as mixotrophy). Mixotrophy is defined as the concurrent utilization of organic (for example, sugars) and inorganic (for example, CO2, CO, and H2) substrates for growth and metabolism. As reviewed4,5, the Wood–Ljungdahl Pathway (WLP), the carbon fixation pathway employed by acetogens to convert CO2:H2, CO or other C1 feedstocks into acetyl-CoA6, is particularly well-suited for mixotrophy because it exhibits a low ATP requirement relative to other carbon fixation pathways5 and requires the exact amount of NAD(P)H generated through glycolysis to fix two molecules of CO2 into one acetyl-CoA7. Thus, one mole of hexose sugar yields three moles of acetyl-CoA and one mole of ATP through WLP-driven mixotrophy. With their ability to utilize gases through the WLP and a broad array of other carbohydrate substrates7, acetogens are an ideal host organism for mixotrophy.

The amount of CO2 re-assimilated with mixotrophy depends upon the degree of reduction of the desired metabolite (product). The more reduced the product, the less CO2 can be re-assimilated, because NAD(P)H is directed towards product formation rather than CO2 fixation. However, this reducing equivalent deficiency can be overcome through H2-enhanced mixotrophy, whereby sufficient H2 is exogenously provided to fully recapture the CO2 lost in glycolysis. To avoid CO2 emissions associated with H2-production, electrolysis of water powered by solar, wind or hydroelectricity would be a preferred source and has achieved a level of maturity and success8,9. Alternatively, syngas can be added to sugar fermentation to provide the necessary reducing power and carbon. As reviewed4,5,10, WLP gas-only fermentation is an ATP-limited process commonly requiring production of acetate from acetyl-CoA, for which acetogens receive their name, to generate sufficient ATP for cell growth and maintenance. Syngas-enhanced mixotrophy mitigates this challenge by supplying cells with abundant ATP through glycolysis.

In this study, we demonstrate the ability of a broad range of acetogenic organisms to conduct mixotrophy and H2- or syngas-enhanced mixotrophy without carbon catabolite repression (CCR), thus enabling sugar to metabolite yields that are not theoretically possible through heterotrophic (that is, traditional) fermentation. Additionally, we demonstrate the ability to produce reduced products without the need for significant co-production of acetate, as is commonly witnessed in autotrophic fermentations10,11. Moreover, we show that sugar can be stoichiometrically converted to reduced products with nearly no CO2 production from glycolysis. Last, we demonstrate the utility of mixotrophy in acetone production using a genetically-engineered acetogen (Clostridium ljungdahlii, abbreviated as CLJ). Acetone, a commodity petrochemical currently produced through the cumene process, has a world market on the order of six million metric tons per year which is valued at nearly eight billion US dollars. This makes acetone an attractive target for renewable, biochemical production given market drivers for bioderived acetone. When grown in a high cell density continuous fermentation system under mixotrophic conditions, we could achieve 138% of the theoretical, heterotrophic fermentation maximum, which is 92% of the theoretical mixotrophic maximum, and this was accomplished with volumetric productivities over 2 g l−1 per hour with acetone titers greater than 10 g l−1.

Results

Concurrent utilization of gas and sugar

A key concern regarding the implementation of mixotrophy (Fig. 1a) is the possibility of CCR of the WLP in the presence of a preferred sugar substrate, as has been shown for two acetogens: Clostridium aceticum12 and Blautia coccoides GA-1 (ref. 13). In contrast, Eubacterium limosum (ELM)14 and Acetobacterium woodii12 were found to concurrently utilize glucose and methanol and fructose and CO2:H2, respectively. To investigate if CCR occurs in CLJ, an important industrial strain15,16, CLJ was grown on C12-fructose and a C13-labelled syngas mixture (13CO:13CO2:H2:N2, 55:10:20:15) and interrogated at the metabolite, transcript and protein levels. CLJ incorporated a surprisingly large percentage of labelled gas into products (Fig. 1c). Between 73% and 80% of acetate, the primary metabolite, exhibited 13C-labelling over the course of the fermentation. Even at the earliest time point (t=24 h), over 70% of acetate was derived from the labelled syngas rather than fructose. We also found no change at either the transcript or protein level of key WLP genes or enzymes, when compared against an autotrophic control (Supplementary Fig. 1), which is consistent with a previous report17. The closely related acetogen C. autoethanogenum (CAU) was also investigated under the same conditions, and we found it too displayed a high degree of 13C-labelled acetate, 51–58% labelled throughout the fermentation (Fig. 1d). Though it was not directly measured, ethanol, for both CLJ and CAU, should have a similar percentage of 13C-labelling, since it is also derived from acetyl-CoA. For both strains, the consistently high percentage of acetate labelling during fructose consumption demonstrates that both glycolysis and WLP operate concurrently, apparently without the limitation of CCR. To our knowledge, this is the first 13C-analysis of metabolites produced during mixotrophy.

Figure 1: The concept of mixotrophy and its demonstration.
Figure 1

(a,b) Different modes of fermentation are shown as an abbreviated metabolic network (a) and block flow diagrams (b). Heterotrophy (case I): hexose is consumed and CO2 and potentially H2 are produced. Mixotrophy (case II): hexose is consumed and excess reducing equivalents are used to fix endogenously produced CO2; any unconsumed CO2 is released from the process. H2-enhanced mixotrophy (case III): hexose along with H2 are fed to the microorganism and no CO2 is released. Syngas-enhanced mixotrophy (case IV): hexose and CO:CO2:H2 are fed to the microorganism. Depending on the composition of the syngas and the metabolite of interest, CO2 may still be released from the process. Dashed lines indicate potential pathways or products. (c,d) 13C-labelling fermentation profiles of CLJ (c) and CAU (d) during syngas-enhanced mixotrophy. Fructose (black line) consumed and metabolites produced during fermentation in the presence of a syngas mixture (13CO, 13CO2, H2 and N2). The percentage of acetate labelled with 13C is shown in light blue for each time point. The s.d. of two biological replicates is shown in black error bars.

Engineered CLJ strain for acetone production

We next sought to demonstrate the potential for mixotrophy to produce an industrially important metabolite at superior yields. Acetone was chosen as a proof-of-principle metabolite because it requires no additional NAD(P)H downstream of acetyl-CoA (Fig. 2a), which allows for all excess reducing equivalents to be used for CO2 fixation. In addition, acetone is an important commodity chemical and a feedstock for poly(methyl methacrylate) production. Acetone is not a natural metabolite of any known acetogen, but recombinant production has been engineered into C. aceticum18,19 and A. woodii20. However, both studies focused primarily on autotrophic growth where significant amounts of acetate were still produced, and although acetone titers and volumetric productivities demonstrate proof-of-principle, results lack industrial relevance. Additionally, an inducible acetone-producing strain of CLJ was previously constructed21, though a recent publication20 has questioned whether isopropanol was actually produced instead of acetone because of the native secondary alcohol dehydrogenase (SADH) activity of CLJ22.

Figure 2: Metabolic engineering of CLJ to demonstrate mixotrophic production of acetone.
Figure 2

(a) Metabolic pathways downstream of pyruvate for the native and engineered CLJ. Native metabolites and enzymes are shown in black, and heterologous enzymes along with non-native metabolites are shown in blue. Integration with the WLP is shown through light blue arrows. The gene deletion is shown in red. PFOR, pyruvate:ferredoxin oxidoreductase; ALS, acetolactate synthase; ALDC, acetolactate decarboxylase; 23BDH, 2,3-butanediol dehydrogenase; SADH, secondary alcohol dehydrogenase; AK, acetate kinase; PTA, phosphotransacetylase; AAD, alcohol:aldehyde dehydrogenase; THL, thiolase; CoAT, CoA-transferase; AADC, acetoacetate decarboxylase. (b,c) Product profiles of CLJ ΔSADH (pTCtA) under mixotrophy and H2-enhanced mixotrophy. Total molar yields (b) and product distributions (c) are shown. The s.d. of three biological replicates is shown in black error bars.

The SADH in CLJ is part of the 2,3-butanediol production pathway to convert acetoin into 2,3-butanediol and works in tandem with a 2,3-butanediol dehydrogenase (2,3-BDH; refs 22, 23) (Fig. 2a). Importantly, this SADH was shown to convert exogenously added acetone into isopropanol22. To prevent this conversion, we deleted the SADH gene (CLJU_c24860) from the chromosome using a homologous recombination approach. We then constructed the acetone-producing plasmid pTCtA, consisting of a thiolase, a CoA-transferase, and an acetoacetate decarboxylase, and introduced it into the deletion strain CLJ ΔSADH. The resulting strain, CLJ ΔSADH (pTCtA), produced mostly acetone and acetate but also 3-hydroxybutyrate (3-HB) and trace amounts of isopropanol. We suspect 3-HB and isopropanol are still being produced to minor degrees because of the endogenous activity of 2,3-BDH, which is acting upon the intermediate acetoacetate to produce 3-HB or upon acetone to produce isopropanol (Fig. 2a).

After 168 h of mixotrophic growth, the total molar yield of CLJ ΔSADH (pTCtA) was 82% (Fig. 2b) with acetone being the primary metabolite at 1.73 g l−1, followed by acetate at 1.54 g l−1 and 3-HB at 0.29 g l−1 (Fig. 2c, Supplementary Table 1). The mass yield of acetone was 34wt% and the mass yield of total acetone pathway products (acetone + 3-HB) was 37wt%. These mass yields are greater than the theoretical maximum acetone yield of 32wt% under standard heterotropic conditions, demonstrating the ability to improve mass yields of products with mixotrophy. However, the total mass yield of acetone pathway products (37wt%) is only 80% of the theoretical maximum under mixotrophic conditions. We, therefore, investigated a high cell-density continuous fermentation process for CLJ ΔSADH (pTCtA) to obtain higher acetone yields.

High cell density continuous fermentation

A potent approach to further improve product (metabolite) yields, minimize biomass formation, reduce ATP demand and increase the availability of reduction energy (available electrons) is through continuous fermentation with cell recycle. Cell recycle can also increase cell density, which has the potential to increase volumetric productivity24. To test this, we setup a high cell density continuous fermentation apparatus that fully retained cells until reaching an optical density at 600 nm (OD600) of 35–60 (Fig. 3a), which corresponds to 10–18 g l−1 cell dry weight. As shown in Fig. 3a, the targeted cell densities were reached 100 h after cell retention was started, at which point a harvest was implemented to maintain a constant cell density. Also at this point, the maximum acetone pathway (that is, acetone, 3-HB, and isopropanol) titer was achieved of 12.7 g l−1 with concurrent acetate titers of 2.5 g l−1. A minor amount of ethanol (0.05–0.78 g l−1, Supplementary Fig. 2) was also produced. Acetone concentrations reached a maximum of 10.8 g l−1 (Supplementary Fig. 2), which was 85% of the total mass of acetone pathway products. Also shown in Fig. 3b, starting at hour 100 and for 50 h afterwards (that is, up to 150 h continuous fermentation time), volumetric productivities of acetone pathway products and acetate remained essentially constant, along with fructose volumetric consumption. The average volumetric productivity of acetone pathway products and acetate was 2.32 and 0.56 g l−1 per hour, respectively, and the average fructose volumetric consumption rate was 5.78 g l−1 per hour. This resulted in an average acetone pathway yield of 40.1wt% (87% of the theoretical mixotrophic maximum). Real-time acetone pathway mass yields ranged from 37.8 to 44.6wt% during this time period (Fig. 3b). A biological replicate continuous fermentation performed similarly (Supplementary Fig. 3). Through subsequent process development, we have achieved 45wt% conversion of acetone pathway products with 5 g l−1 per hour volumetric productivity and 23 g l−1 titer of acetone pathway products with less than 3 g l−1 acetate.

Figure 3: High cell density continuous acetone fermentation.
Figure 3

Fermentation performance for 150 h of cell retention fermentation. At hour 96, a harvest was initiated to maintain a constant cell density. Titers and cell densities (a) are shown in addition to volumetric productivities and the total acetone pathway (acetone, 3-HB, and isopropanol) product yield (b). (a) Acetone pathway titers (blue diamond), acetate titers (orange triangle) and cell densities (grey circle with broken line). (b) Fructose volumetric consumption (black squares), acetone pathway volumetric productivity (blue diamonds), acetate volumetric productivity (orange triangles) and acetone pathway mass yield (%g g−1) from consumed fructose (red circle with broken line). Individual product and fructose titers are shown in Supplementary Fig. 2.

H2 enhanced mixotrophy leads to complete carbon utilization

Though production of acetone does not require additional NAD(P)H, the pathway has a decarboxylation step (Fig. 2a), which generates one mole of CO2 for every acetone mole produced. Under mixotrophic conditions, there is insufficient NAD(P)H to re-assimilate this additional CO2, resulting in net CO2 production (Fig. 2c, 0% H2). This limitation can be overcome with H2-enhanced mixotrophy, where H2 provides the necessary reducing power to fix all CO2. In the presence of either 20% or 40% (v v−1) H2, the overall molar yields of metabolites for CLJ ΔSADH (pTCtA) were >90% (Fig. 2b), and essentially all CO2 was fixed into metabolites (Fig. 2c). However, under these highly reduced conditions, H2 not only led to complete carbon capture but also caused the strain to favour reduced products, like ethanol, over less reduced products, like acetone. This caused a shift in the metabolite profile, with the primary metabolite now ethanol at 2.42 g l−1 or 1.96 g l−1, for 20% and 40%, respectively, and acetone being reduced to 1.02 g l−1 or 0.81 g l−1, respectively (Supplementary Table 1). Nevertheless, these data demonstrate the power of this technology to enable complete carbon utilization. Directing the carbon to the desirable product will require further strain engineering to eliminate the formation of undesirable products and using only the necessary amount of H2 needed to achieve the zero CO2 loss goal.

Mixotrophy is a general trait of acetogens

With the successful demonstration of mixotrophy in CLJ and CAU, we wanted to examine if mixotrophy was a more general trait among acetogens. Therefore, we tested two additional acetogens, Moorella thermoacetica (MTA) and ELM, for mixotrophy. ELM was previously shown to consume both glucose and methanol14, the latter being utilized through the methyl or ‘Eastern’ branch of the WLP6. Here we wanted to test for concurrent sugar and gas utilization. All four strains (CLJ, CAU, MTA and ELM) were tested under both mixotrophic conditions and syngas-enhanced mixotrophic conditions. In addition, a heterotrophic control was prepared with the anaerobic bacterium C. acetobutylicum (CAC), which is related to many acetogens but has no native carbon fixation pathway. Under mixotrophy, all acetogens achieved carbon molar yields greater than the 67% theoretical maximum yield (Cproduct moles Chexose consumed moles−1) that can be achieved without carbon fixation (Fig. 4a). The carbon yields for CAU and ELM were less than those for CLJ and MTA, presumably because CAU and ELM produced a larger percentage of reduced products (ethanol for CAU and butyrate for ELM, Fig. 4b), thus reducing the amount of CO2 that can be fixed. Under syngas-enhanced mixotrophic conditions, the apparent carbon molar yields from sugar, as shown in Fig. 4a, for all acetogen species increased beyond the mixotrophic yields. In addition, the syngas mixture affected the product profiles with all strains, with more reduced products now being favoured (Fig. 4c). This shift occurs because of the added reducing power of the syngas mixture (55% CO and 20% H2), which the cells are able to utilize to produce more reduced products. While acetate was still the primary metabolite, ethanol and 2,3-butanediol production increased in both CLJ and CAU, lactate production increased in MTA, and butyrate production increased in ELM (Fig. 4c). Demonstration of mixotrophy in these four strains, along with the demonstration in A. woodii previously12, would argue that mixotrophy is a general trait of all acetogens, though to varying degrees.

Figure 4: Mixotrophy is a general trait of acetogens.
Figure 4

(a) Carbon molar yields (CM CS−1; Cmetabolites Csubstrate−1), defined as the carbon moles produced divided by sugar carbon moles consumed, of C. acetobutylicum (CAC), C. ljungdahlii (CLJ), C. autoethanogenum (CAU), M. thermoacetica (MTA) and E. limosum (ELM) grown under different conditions. Cultures were grown on fructose with either a N2 headspace (heterotrophy and mixotrophy) or a syngas headspace (syngas-enhanced mixotrophy). The red dashed line indicates a yield of 67%. (b,c) Product profiles of CLJ, CAU, MTA and ELM under mixotrophy (b) or syngas-enhanced mixotrophy (c) are shown. Yields of CO2 in b are calculated based on total carbon consumed for each strain. The s.d. of three biological replicates is shown in black error bars.

Mixotrophy benefits for other metabolites

To highlight the potential of mixotrophic fermentations, we calculated the theoretical maximum yield for many metabolites of interest via mixotrophy and H2-enhanced mixotrophy (Fig. 5a). Yield improvements are modest for more reduced products, such as ethanol and n-butanol, while yield improvements are significant for less reduced products including carboxylic acids. Generally, the ratio of mixotrophic to heterotrophic product yield is inversely proportional to the ratio of NAD(P)H to acetyl-CoA required to produce a given chemical (Supplementary Table 2). Accordingly, the NAD(P)H to acetyl-CoA ratio can be used to quickly determine the potential yield improvement from mixotrophy for most metabolites with acetyl-CoA as a precursor (Table 1). With H2-enhanced mixotrophy (Fig. 5a), product yields based on sugar mass increased 49–100% for all metabolites, aside from acetate, and the quantities of H2 required for supplementation range from 0.017–0.065 g H2 g glucose−1 (Fig. 5b). As with the mixotrophic results, the chemicals that require the most reducing energy also require the largest amount of H2 to fix all CO2, and the amount of exogenous H2 required is directly proportional to the NAD(P)H to acetyl-CoA ratio (Table 1). Since H2-enhanced mixotrophy removes electron constraints, the chemicals that showed the smallest yield improvements from heterotrophy to mixotrophy show the largest yield improvements from mixotrophy to H2-enhanced mixotrophy. For syngas-enhanced mixotrophy, similar yield improvements can be achieved using CO as the electron donor though CO2 is generated in the process. In order to minimize net CO2 production, a mixture of CO and H2 is needed, and the ideal mixture is dependent upon the target metabolite. In this case, yields can be increased beyond those calculated here because the gaseous carbon can be fixed into metabolites, as seen in Fig. 4a,c.

Figure 5: Theoretical yields for various metabolites to demonstrate the potential of mixotrophy.
Figure 5

(a) Calculated maximum biological mass yields for several metabolites of interest under heterotrophic, mixotrophic and H2-enhanced mixotrophic conditions (where only enough H2 is supplemented to consume all CO2 evolved). Amounts of H2 required to achieve these yields are shown in b. 2,3-BD, 2,3-butanediol; 1,4-BD, 1,4-butanediol; 3-HB, 3-hydroxybutyrate; 2-HIB, 2-hydroxyisobutyrate.

Table 1: Correlation between NAD(P)H:acetyl-CoA ratio to improvement in product yields with mixotrophy.

Discussion

Mixotrophic behaviour has been previously reported, such as the stoichiometric conversion of sugar into acetate by MTA25 and the co-consumption of sugar and C1 feedstocks for A. woodii12 and E. limosum14. However, the potential of mixotrophy to increase product yields beyond previous theoretical limits, and its application to industrial biotechnology has largely been overlooked. Here we more thoroughly demonstrate that mixotrophy takes place and is a general trait of all four acetogens tested. Moreover, we genetically engineered a CLJ strain to produce acetone at a product yield that is 138% of the previous theoretical maximum, which was calculated based on heterotrophy alone. This significant increase in product yield could convert a previously uneconomical fermentation process into an economically viable one.

Though mixotrophy is a general trait among acetogens, allowing for the application of different strains for different metabolites or processes, the work in this study largely used CLJ as a mixotrophic host for several reasons. First, CLJ has proven to be genetically malleable, with several key genetic tools now available, including plasmid overexpression15,16, inducible plasmid expression21, chromosomal deletions16,26 and chromosomal integrations27. The ability to genetically manipulate CLJ allows for the possibility to increase production of minor metabolites or introduce pathways to produce non-native metabolites, like acetone in this study. Another trait that makes CLJ a desirable mixotrophic host is the surprising result from the 13C-labelling analysis that in the presence of both sugar and gases, CLJ produced more acetate from the gaseous substrate than the sugar substrate. Indeed, over 70% of the produced acetate was labelled with 13C (Fig. 1c). Over the first 72 h, CLJ produced almost 6 g l−1 of acetate from about 2 g l−1 of consumed fructose. This is compared with the related CAU strain, which over the same period consumed 6.3 g l−1 of fructose and produced 3.6 g l−1 of acetate and 2.8 g l−1 of ethanol for a total of 6.4 g l−1 of product. In addition, the overall rate of fructose consumption in CLJ was significantly less than that in CAU. Over the 168 h fermentation, CLJ consumed only 3 g l−1 of fructose while CAU consumed over 9.6 g l−1 of fructose. One likely explanation for this divergent behaviour is the potentially inhibitory levels of acetate, which is a well-known inhibitor of many fermentations28. As shown in Fig. 1c,d, by 72 h, CLJ had produced almost 6 g l−1 of acetate while this titer was not reached in CAU until after 120 h. This will be further investigated to understand the differing behaviour of these two related strains.

Another important area that needs additional research and understanding is the effects the two types of substrates, organic and inorganic, have on enhanced mixotrophy. Here we tested only fructose with H2 and fructose with a syngas mixture (CO:H2:CO2:N2, 55:20:10:15), however many different organic and inorganic substrates can be used such as other sugars, gas compositions, methanol, formate, and other C1 substrates. Gaining a better understanding of the effect of all these possible substrates and their impact on product formation is crucial to best pair potential feedstocks for producing products of interest. An example of this effect can be observed in the syngas-enhanced mixotrophy results (Fig. 4). In those experiments, CLJ and CAU outperformed MTA and ELM in terms of total product yield from sugar (195 and 165% yields versus 119 and 86% yields, Fig. 4a). However, it is unclear whether these differences in performance are related to the strains themselves or rather the conditions tested. For example, the syngas composition may not have been ideal for MTA or ELM.

Beyond a fundamental analysis, the data from the high cell density continuous fermentation (Fig. 3) constitute a foundation for further development to achieve industrially relevant productivities, unprecedented mass yields and increased product titers.

Methods

Strains and growth conditions

C. ljungdahlii DSM-13528 (CLJ), C. autoethanogenum DSM-10061 (CAU), E. limosum DSM-20543 (ELM) and M. thermoacetica DSM-521 (MTA) were obtained from DSMZ (Braunschweig, Germany). All cultures were grown in sealed serum bottles in a shaking incubator (150 r.p.m.) at 37 °C, except for MTA which was incubated at 55 °C. They were cultivated anaerobically in American Type Culture Collection (ATCC) medium 1754 with 10 g l−1 of fructose, with the exception of ELM which was grown in a modified ATCC medium 1754 (supplemented with 10 g l−1 MES, pH 6.0) with 5 g l−1 of fructose. Growth was monitored by measuring the optical density at 600 nm (OD600). A 5% inoculum of mid-exponential phase (OD600 of 0.8–1.5) was used to inoculate 160-ml serum bottles (Wheaton), with 50 ml of culture media and 110 ml of gas headspace. For autotrophic and syngas enhanced mixotrophic cultures, the headspace was pressurized to 30 psig with syngas (CO:CO2:H2:N2, 55:10:20:15), except for ELM which was pressurized to 20 psig. MTA was grown in a mixture without CO (CO2:H2, 80:20). Heterotrophic and mixotrophic cultures were pressurized to 20 psig with N2. The pH of the cultures was monitored and kept between 5.0–6.5 by adding 4M NH4OH.

13C Metabolite labelling

CLJ and CAU were grown as described above with 10 g l−1 of 12C-fructose. The syngas-enhanced mixotrophic and autotrophic cultures contained a mixture of syngas (13CO:13CO2:H2:N2, 55:10:20:15) with all carbons labelled. Samples were taken at early, mid and late exponential phase and metabolites and biomass was analysed for 13C content. Gas chromatography–mass spectrometry analysis of 13C-labelling was performed on an Agilent 7890A GC system equipped with a DB-5 MS capillary column connected to a Waters Quattro Micro Tandem Mass Spectrometer operating under ionization by electron impact at 70 eV (ref. 29).

Construction of CLJ ΔSADH (pTCtA)

The SADH gene in CLJ (CLJU_c24860) was deleted from the genome, as this enzyme readily converts acetone into isopropanol22. A replicating plasmid was constructed and transformed into CLJ to completely delete the gene using a homologous recombination technique. Two regions of homology, each about 1,400 bp in length, were PCR amplified from CLJ genomic DNA using the primers listed in Supplementary Table 3. These two regions were then PCR assembled, with a NotI restriction enzyme site in-between the two regions, and ligated into a pCR8:GW:TOPO TA entry plasmid (ThermoFisher Scientific). The chloramphenicol and thiamphenicol resistance gene from pSOS95-Cm was then PCR amplified, digested with NotI and ligated into the entry plasmid in between the two regions of homology. The integration cassette was then transferred from the entry plasmid to a custom destination plasmid using the Gateway LR Clonase II Enzyme mix (ThermoFisher Scientific). The custom destination plasmid was a modified pSOS95-based plasmid30, where the expression cassette (including the transcriptional promoter and terminator) were replaced with the Gateway destination cassette and the repL episome was replaced with the episome from pNW33N (Bacillus Genetic Stock Centre, Columbus, Ohio).

The deletion plasmid was transformed into CLJ WT, using a protocol similar to the previously published protocol16. CLJ WT cultures were grown in 100 ml of ATCC medium 1754 with 5 g l−1 until an OD600 of between 0.2–0.3. Cells were then harvested by centrifugation anaerobically and washed twice in anaerobic SMP buffer (270 mM sucrose, 1 mM MgCl2, 7 mM sodium phosphate, pH 6). Cells were finally resuspended in 150 μl of antifreezing buffer (90:10 SMP: dimethylsulphoxide) and divided into 25 μl aliquots. Aliquots were mixed with 1 μg of plasmid DNA and then transferred to a 1 mm cuvette. Cells were pulsed at 625 V with a resistance of 600 Ω and a capacitance of 25 μF using a Gene Pulser Xcell system (Bio-Rad). Cells were immediately mixed with 1 ml of ATCC 1754 medium and transferred to a 15 ml conical tube with 4 ml of ATCC 1754 medium. Cultures were incubated anaerobically at 37 °C for 16–20 h, until the cultures became turbid. Cells were then harvested by centrifugation and resuspended in 1 ml of ATCC 1754 medium. Four-hundred fifty microlitres of resuspended cells were then mixed with 25 ml of reinforced clostridial medium (RCM) molten agar (0.8%) with 5 μg ml−1 thiamphenicol and poured into a petri dish. After the agar plates solidified, they were turned upside down and incubated anaerobically at 37 °C until colonies developed (3–5 days). Once developed, individual colonies were selected and grown in ATCC medium 1754 with 5 g l−1 fructose and 5 μg ml−1 thiamphenicol up to an OD600 of about 1.0. They were then serial diluted and plated onto RCM plates with 5 μg ml−1 thiamphenicol. Plates with individual colonies were replica plated onto fresh RCM plates with 40 μg ml−1 erythromycin. Colonies which grew on thiamphenicol but were sensitive to erythromycin were selected, and deletion of CLJU_c24860 was confirmed via PCR and by sequencing of the local locus.

Plasmid pTCtA was constructed from a pSOS95-derived plasmid30. On the plasmid backbone, the repL episome was replaced with the episome from pNW33N and the expression cassette, including the transcriptional promoter, was removed except for the rho-independent terminator using a SbfI:KasI digestion. A synthetic acetone production operon was constructed consisting of the CLJ pta-ackA promoter (Ppta), the thiolase gene from C. kluyveri DSM 555 (CKL_3698, thl), the CoA-transferase gene from CAC (CA_P0163&0164, ctfAB), and the acetoacetate decarboxylase gene from CAC (CA_P0165, adc). All regions were amplified from genomic DNA using the primers listed in Supplementary Table 3. The synthetic operon was PCR assembled and then ligated into the modified backbone using the SbfI:KasI digestion. The plasmid was finally transformed into the CLJ ΔSADH and selected for using erythromycin (40 μg ml−1 for solid agar plates and 100 μg ml−1 for liquid media).

Batch fermentations of CLJ ΔSADH (pTCtA)

Cultures of CLJ ΔSADH (pTCtA) were carried out in anaerobic ATCC medium 1754 with 5 g l−1 fructose and 100 μg ml−1 erythromycin in sealed 160-ml serum bottles, in a similar manner as described above. The atmosphere was either 30 psig N2 or 30 psig of an H2:N2 mixture.

High density cell recycle fermentations

A 10% inoculum of mid-exponential phase (OD600 of 0.8–1.5) CLJ ΔSADH (pTCtA) culture was used to inoculate a 3 l bioreactor (Applikon) with a 1.9 l working volume of anaerobic ATCC medium 1754 with 5 g l−1 fructose and 5 μg ml−1 of clarithromycin. Cultures were sparged with N2 for the first 24 h to maintain an anaerobic environment as the cultures entered exponential growth. Once the cultures reached an OD600 of 1.5, cell-recycle was initiated. Fermentation pH was controlled from dropping below 5.0 using 4M NH4OH. Fermenter feeding and permeate rates were balanced to maintain a constant working volume and the average rate was 3–6 ml min−1. Cell retention was accomplished with a 0.15 ft2, 0.1 μM Graver Technologies (Newark, DE, USA) sintered stainless steel microfiltration membrane. The feed rate to the membrane was 150 ml min−1 and the recirculation rate was 6.5 l min−1. The retentate rate was between 144–147 ml min−1, which equaled the membrane feed rate minus the permeate rate. The culture was in complete cell retention until reaching an OD600 of 35–60, at which time a harvest was started that was equal to the critical dilution rate that maintained a constant cell density in the fermenter. Fructose concentration in the feed was increased to as high as 80 g l−1 during the course of building cell density, and the concentration of clarithromycin was maintained at 5 μg ml−1.

Detection of metabolites

Culture supernatant samples were quantified using an Agilent HPLC instrument with a Bio-Rad Aminex HPX 87H column using a 5 mM H2SO4 mobile phase31. Gas samples were analysed using an Agilent GC instrument with a Supelco 60:80 Carboxen-1,000 column, used according to the manufacturer’s recommendation.

RNA isolation and quantitative reverse transcription (qRT–PCR)

RNA was extracted using the RNEasy Kit (Qiagen) with a modified protocol as follows: cells were thawed on ice and washed and resuspended in 220 μl RNase-free SET buffer +20 μl proteinase K. Samples were sonicated for 10 min using 15 s pulse on:off at 40% amplitude in a Fisher Scientific Sonic Dismembrator. In all, 1 ml of Trizol was added to each sample, split in two and another 400 μl Trizol was added to have the final volume of 1 ml. 200 μl of ice-cold chloroform were added to the sample and mixed for 15 s, then incubated at room temperature for 3 min. Samples were spun at >12,000g for 15 min at 4 °C. Upper aqueous phase was mixed with 500 μl of 70% ethanol and RNEasy protocol was followed per manual. Sample concentration was determined using a NanoDrop (Thermo Scientific). Concentrations ranged from 50 ng μl−1–600 ng μl−1 depending on the sample.

Complementary DNA (cDNA) was synthesized using high capacity cDNA reverse transcription kit (Applied Biosystems). In all, 1 μl of cDNA was used in qRT–PCR experiments using the SYBR green kit (BioRad) following the manufacturer's protocol. Primers are listed in Supplementary Table 2. Each sample was tested with three technical replicates and three biological replicates. All technical replicates were averaged. The housekeeping gene was CLJ_c12520 (gpk, guanylate kinase)23. Fold changes were calculated using the autotrophic condition as the control case and either mixotrophy or syngas-enhanced mixotrophy as the experimental condition. All calculations were done using Graph Pad PRISM software with statistical analysis using two-way analysis of variance of the ΔCT between the three conditions (autotrophy, mixotrophy and syngas-enhanced mixotrophy).

Western blots

Cells were harvested by centrifugation at 4 °C for 10 min at 7,000g. The cell pellets were frozen at −82 °C. The cell pellets were then resuspended in 500 μl of 100 mM Tris-HCl (pH 7.0) (Buffer A). The samples were sonicated using a Fisher Scientific Sonic Dismembrator for 15 s pulse on:off at 50% amplitude for 10 min. The samples were spun down for 10 min at 13,000g. The supernatant was collected and the cell debris was resuspended in same amount of Buffer A. The samples were mixed in a 1:5 dilution with 5 × loading buffer (0.2 M Tris-HCl (pH 6.8), 10% SDS, 1.43M 2-mercaptoethanol, 0.05% bromophenol blue, 50% glycerol) and boiled at 95 °C for 10 min. A volume of 30–50 μl of aliquots were loaded onto the Genscript ExpressPlus PAGE Gel, 4–20% gradient and run at 120 V for 2 h. The gels were transferred using the BioRad mini-trans blot system. The custom polyclonal antibodies against the CODH subunit were designed through ProteinTech and obtained from rabbit serum. The AP colourimetric kit (Anti-Rabbit Assay Kit #1706460, BioRad) was used to visualize the bands using a 1:10,000 dilution of the polyclonal antibodies in TBS and Tween 20, following the supplier’s recommendations.

Stoichiometric and energetic model

The stoichiometric and energetic model was created for combined glycolysis and WLP that maximizes production of a specific metabolite, while assuming 5% of all carbon goes towards biomass formation, as previously detailed4. Briefly, the model considers ATP and acetyl-CoA production according to equations 1 and 4. Equation 1 describes CO2 fixation via the WLP. Included in equation 1 is an ATP conservation coefficient (n), which accounts for ATP generated through membrane-bound ATPases, driven by cytochrome- or Rnf-created H+ or Na+ membrane gradients. For the calculations presented here, n=0.9. Equation 4 represents ATP, acetyl-CoA, CO2 and reducing equivalent production from glycolysis of hexose sugar to acetyl-CoA. Cell production was defined according to equation 2. Reducing equivalent production from hydrogen was modelled according to equation 3.

Mcell is the molecular weight of cell biomass, and a value of 26 g mol−1 is used32. YATP is the ATP yield coefficient, defined as gcells molATP−1, and a value of 6.5 gbiomass molATP−1 was used, as determined in ref. 33. C-mole Biomass (CH2.08O0.53N0.24) is the molecular formula for biomass as determined in ref. 32. NAD(P)+/NAD(P)H stands for nicotinamide adenine dinucleotide or nicotinamide adenine dinucleotide phosphate. NAD(P)+ is the oxidized form, and NAD(P)H is the reduced form. H+ is a proton. Subsequent metabolic equations were added for each metabolite analysed.

Data availability

All relevant data are included with the manuscript (as figure source data or supplementary information files), and all data is available upon reasonable request from the corresponding author.

Additional information

How to cite this article: Jones, S. W. et al. CO2 fixation by anaerobic non-photosynthetic mixotrophy for improved carbon conversion. Nat. Commun. 7:12800 doi: 10.1038/ncomms12800 (2016).

References

  1. 1.

    Reassessing the progress in the production of advanced biofuels in the current competitive environment and beyond: what are the successes and where progress eludes us and why. Ind. Eng. Chem. Res. 54, 10170–10182 (2015).

  2. 2.

    , & Non-fermentative pathways for synthesis of branched-chain higher alcohols as biofuels. Nature 451, 86–89 (2008).

  3. 3.

    , & Synthetic non-oxidative glycolysis enables complete carbon conservation. Nature 502, 693–697 (2013).

  4. 4.

    , , & Acetogenic mixotrophy: novel options for yield improvement in biofuels and biochemicals production. Curr. Opin. Biotechnol. 33, 60–72 (2015).

  5. 5.

    & Stoichiometric and energetic analyses of non-photosynthetic CO2-fixation pathways to support synthetic biology strategies for production of fuels and chemicals. Curr. Opin. Chem. Eng. 1, 380–395 (2012).

  6. 6.

    & Acetogenesis and the Wood-Ljungdahl pathway of CO2 fixation. Biochim. Biophys. Acta 1784, 1873–1898 (2008).

  7. 7.

    , , , & Clostridia: the importance of their exceptional substrate and metabolite diversity for biofuel and biorefinery applications. Curr. Opin. Biotechnol. 23, 364–381 (2012).

  8. 8.

    , , & An overview of hydrogen production technologies. Catal. Today 139, 244–260 (2009).

  9. 9.

    et al. Engineering heterogeneous semiconductors for solar water splitting. J. Mater. Chem. A 3, 2485–2534 (2015).

  10. 10.

    & Bioenergetic constraints for conversion of syngas to biofuels in acetogenic bacteria. Biotechnol. Biofuels 8, 210 (2015).

  11. 11.

    , & Carbon monoxide fermentation to ethanol by Clostridium autoethanogenum in a bioreactor with no accumulation of acetic acid. Bioresour. Technol. 186, 122–127 (2015).

  12. 12.

    & Effect of molecular hydrogen and carbon dioxide on chemo-organotrophic growth of Acetobacterium woodii and Clostridium aceticum. Arch. Microbiol. 128, 294–298 (1981).

  13. 13.

    et al. Influence of glucose fermentation on CO2 assimilation to acetate in homoacetogen Blautia coccoides GA-1. J. Ind. Microbiol. Biotechnol. 42, 1217–1224 (2015).

  14. 14.

    , , & Kinetics and physiological implications of the growth behavior of Eubacterium limosum on glucose/methanol mixtures. J. Gen. Microbiol. 138, 979–985 (1992).

  15. 15.

    et al. Clostridium ljungdahlii represents a microbial production platform based on syngas. Proc. Natl Acad. Sci. USA 107, 13087–13092 (2010).

  16. 16.

    , , & A genetic system for Clostridium ljungdahlii: a chassis for autotrophic production of biocommodities and a model homoacetogen. Appl. Environ. Microbiol. 79, 1102–1109 (2013).

  17. 17.

    et al. Characterizing acetogenic metabolism using a genome-scale metabolic reconstruction of Clostridium ljungdahlii. Microb. Cell Fact. 12, 118 (2013).

  18. 18.

    Heterofermentative Acetonproduktion Ph.D. thesis, Univeristy of Ulm, Germany (2011).

  19. 19.

    & Pathway engineering and synthetic biology using acetogens. FEBS Lett. 586, 2191–2198 (2012).

  20. 20.

    et al. Acetone production with metabolically engineered strains of Acetobacterium woodii. Metab. Eng. 36, 37–47 (2016).

  21. 21.

    , , , & Lactose-inducible system for metabolic engineering of Clostridium ljungdahlii. Appl. Environ. Microbiol. 80, 2410–2416 (2014).

  22. 22.

    et al. Reconstruction of an acetogenic 2,3-butanediol pathway involving a novel NADPH-dependent primary-secondary alcohol dehydrogenase. Appl. Environ. Microbiol. 80, 3394–3403 (2014).

  23. 23.

    et al. 2,3-Butanediol production by acetogenic bacteria, an alternative route to chemical synthesis, using industrial waste gas. Appl. Environ. Microbiol. 77, 5467–5475 (2011).

  24. 24.

    & Continuous and biomass recycle fermentations of Clostridium acetobutylicum part 1: ATP supply and demand determines product selectivity. Bioprocess Eng. 4, 1–10 (1989).

  25. 25.

    , , , & A new type of glucose fermentation by Clostridium thermoaceticum. J. Bacteriol. 43, 701–715 (1942).

  26. 26.

    , , , & The Rnf complex of Clostridium ljungdahlii is a proton-translocating ferredoxin:NAD+ oxidoreductase essential for autotrophic growth. MBio 4, e00406–e00412 (2012).

  27. 27.

    , , & Converting carbon dioxide to butyrate with an engineered strain of Clostridium ljungdahlii. MBio 5, e01636–01614 (2014).

  28. 28.

    , & A comparative view of metabolite and substrate stress and tolerance in microbial bioprocessing: from biofuels and chemicals, to biocatalysis and bioremediation. Metab. Eng. 12, 307–331 (2010).

  29. 29.

    , , , & Parallel labeling experiments validate Clostridium acetobutylicum metabolic network model for 13C metabolic flux analysis. Metab. Eng. 26, 23–33 (2014).

  30. 30.

    , & Development and characterization of a gene expression reporter system for Clostridium acetobutylicum ATCC 824. Appl. Environ. Microbiol. 65, 3793–3799 (1999).

  31. 31.

    , & Improved acetone-butanol fermentation analysis using subambient HPLC column temperature. Enzyme Microb. Technol. 12, 24–27 (1990).

  32. 32.

    Equations and calculations for fermentations of butyric acid bacteria. Biotechnol. Bioeng. 26, 174–187 (1984).

  33. 33.

    , , , & Methanogenic archaea: ecologically relevant differences in energy conservation. Nat. Rev. Microbiol. 6, 579–591 (2008).

Download references

Acknowledgements

This work was supported by the US National Science Foundation STTR Phase I program under Award IIP-1346424.

Author information

Author notes

    • Shawn W. Jones
    • , Alan G. Fast
    •  & Ellinor D. Carlson

    These authors contributed equally to this work

Affiliations

  1. White Dog Labs, Inc., 15 Reads Way, New Castle, Delaware 19720, USA

    • Shawn W. Jones
    • , Carrissa A. Wiedel
    •  & Bryan P. Tracy
  2. Department of Chemical and Biomolecular Engineering and the Delaware Biotechnology Institute, University of Delaware, 15 Innovation Way, Newark, Delaware 19711, USA

    • Alan G. Fast
    • , Ellinor D. Carlson
    •  & Eleftherios T. Papoutsakis
  3. Department of Chemical and Biomolecular Engineering and Metabolic Engineering and Systems Biology Laboratory, University of Delaware, 150 Academy Street, Newark, Delaware 19716, USA

    • Jennifer Au
    •  & Maciek R. Antoniewicz

Authors

  1. Search for Shawn W. Jones in:

  2. Search for Alan G. Fast in:

  3. Search for Ellinor D. Carlson in:

  4. Search for Carrissa A. Wiedel in:

  5. Search for Jennifer Au in:

  6. Search for Maciek R. Antoniewicz in:

  7. Search for Eleftherios T. Papoutsakis in:

  8. Search for Bryan P. Tracy in:

Contributions

S.W.J. performed many of the fermentation experiments, analysed the data and wrote the paper. A.G.F performed some of the fermentation experiments, did the modelling analysis and wrote the paper. E.D.C. performed some of the fermentation experiments, the qRT–PCR, western blots and wrote the paper. J.A. and M.R.A performed the 13C analysis. E.T.P analysed data and wrote the paper. B.P.T. designed the study, analysed the data and wrote the paper. S.W.J, A.G.F. and E.D.C. contributed equally to the study. All authors discussed the results and commented on the manuscript.

Competing interests

White Dog Labs is commercializing a mixotrophy-based fermentation process and has filed a patent application PCT:US2016:019760.

Corresponding author

Correspondence to Bryan P. Tracy.

Supplementary information

PDF files

  1. 1.

    Supplementary Information

    Supplementary Figures 1-3, Supplementary Tables 1-3

  2. 2.

    Peer Review File

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/ncomms12800

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.